News tagged with disease recurrence

Adjuvant alectinib improves disease-free survival in lung cancer

Adjuvant alectinib improves disease-free survival compared with platinum-based chemotherapy among patients with resected ALK-positive non-small cell lung cancer (NSCLC), according to a study published in the April 11 issue ...